Medicinal Cannabis Cbd And Hemp Products

CPH set to expand in $300M Latin American CBD market

Finfeed Archived Jun 04, 2021

The expansion of its comprehensive distribution agreement with leading nutritional supplements company Route2 Pharm Pvt Ltd, will allow for distribution of Creso Pharma Limited's (ASX: CPH, FRA: 1X8) hemp derived therapeutic products sold under the cannaQIX® and CannaDOL brands into Ecuador.

Bod’s first sales in US a precursor for further revenue generation

Finfeed Archived Apr 07, 2021

Bod Australia (ASX: BDA) has received a maiden $312,000 purchase order for the US from global partner, Health & Happiness Group.